NewsCuraleaf Enters Europe’s Largest Medical Cannabis Market Following EMMAC...

Curaleaf Enters Europe’s Largest Medical Cannabis Market Following EMMAC Move

-

FOLLOWING its recent acquisition of UK-firm EMMAC Life Sciences leading US player Curaleaf has wasted no time in expanding into Europe’s biggest medical cannabis market.

Curaleaf International (formerly EMMAC), through its wholly owned subsidiary Adven has launched its own range of medical cannabis products into Germany.  

It says the initial product launch of a high-THC oil product will be extended over the next few months to incorporate a number of different strengths and THC/CBD formulations in both oils and flower. 

Adven Managing Director Julian Vaterrodt said: “German patients and practitioners are increasingly demanding high-quality, consistent and reliable European natural alternatives to help manage a wide range of complaints.  

“Adven is committed to providing a differentiated product and service for the German market.”

Antonio Costanzo, CEO of Curaleaf International, added: “Curaleaf International’s European supply chain, from cultivation to product research and development and EU-GMP manufacturing processes across Europe, means we are able to guarantee a consistency of product and price to clinicians and patients in need of the highest quality medical cannabis.”

In its recent sixth European Cannabis Report Prohibition Partners estimates Germany had 128,000 active patients at the end of 2020. 

Its medical cannabis products are currently sourced from a wide range of countries including Canada, Netherlands, Uruguay, Portugal, Israel, Spain and Australia.

Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Bloomwell’s €10m Cash Boost To Support Preparations For Germany’s Adult-Use Market

LEADING German medical cannabis healthcare company The Bloomwell Group, is preparing for a major push into the recreational market...

DEMECAN Receives GMP Certificate For Cannabis Production Facility

*Saxony Awards Manufacturing Licence For Medical Cannabis*DEMECAN ensures compliance with highest quality criteria*Way cleared for first cannabis flower delivery...

Good News For CBD Industry After France’s Highest Court Suspends Government Ban On Flowers

THE French CBD industry is celebrating after Government efforts to outlaw the sale of CBD flowers were suspended by...

LGP Signs Exclusive Distribution Agreement With Pharmaserve Hellas

*LGP signs four-year agreement with PharmaServe for the distribution of LGP-branded oil medicines and cannabis flower in Greece *Under the...

New February Deadline Set For CBD Companies Looking To Secure UK Novel Food Authorisation

THE UK Food Standards Agency has set a new deadline of the end of February for the submission of...

IM Cannabis Announces Focus Medical’s Import Of 400 Kilograms Of Premium Indoor-Grown Dried Cannabis From Canada To Israel

Toronto, Canada and Glil Yam, Israel - IM Cannabis Corp. (the “Company” or “IM Cannabis”) (CSE: IMCC, NASDAQ: IMCC),...

Must read

Good News For CBD Industry After France’s Highest Court Suspends Government Ban On Flowers

THE French CBD industry is celebrating after Government efforts...

New February Deadline Set For CBD Companies Looking To Secure UK Novel Food Authorisation

THE UK Food Standards Agency has set a new...

You might also likeRELATED
Recommended to you